Clinical Trial Update: C11-Erlotinib PET/CT as a Tool for Identification and Characterization of Tumor With High Expression of Epidermal Growth Factor Receptor(EGFR).

View source ↗

Summary

A clinical trial update evaluating C11-labeled erlotinib PET/CT to identify and characterize tumors with high EGFR expression in lung cancer and pancreatic canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• C11-Erlotinib (erlotinib (radiolabeled with carbon-11))

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Lung Cancer, Pancreatic Cancer | Status: UNKNOWN